AI system, physicians square off in imaging contest

In the latest man-versus-machine showdown, an artificial intelligence (AI) system faced-off against 15 top physicians from across China to see which could produce the most correct diagnoses in the least amount of time, Ecns.cn reported. 

This time around, machine won out. The AI system, developed by the AI Research Center for Neurological Disorders and Capital Medical University at the Beijing Tiantan Hospital, achieved 83 percent accuracy in classifying brain hematoma expansion cases, compared to the 63 percent achieved by physicians.

Overall the system diagnosed 87 percent of 225 cases read in nearly 15 minutes, compared to 66 percent accuracy in 30 minutes achieved by the humans. The system may have won the battle, but it hasn’t won the war, said Paul Parizel, chair of radiology at Antwerp University Hospital in Belgium and a member of the jury for the contest.

"It will be like a GPS guiding a car. It will make proposals to a doctor and help the doctor diagnose," Parizel said. "But it will be the doctor who ultimately decides, as there are a number of factors that a machine cannot take into consideration, such as a patient's state of health and family situation."

Read the full story below.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.